provided by family physicians (66%). At the beginning of the study period, serum testosterone measured in an estimated 43% of men, and this increased in the pre-intervention time period by 0.2% per month; there was no significant change in this trend after Nov 2014 (p¼0.27). We identified 60,209 men with a new diagnosis of prostate cancer. The median age was 67 , and approximately 2/3 were stage 1 or 2. At the beginning of the study period, bone scans were performed in an estimated 18% of men undergoing active surveillance, and this decreased by 0.05% per month in the pre-intervention time period; there was no significant change in this trend after Nov 2014 (p¼0.07).
INTRODUCTION AND OBJECTIVES: Population-based studies to advance bladder cancer care require longitudinal pathology data that allow measurement of disease recurrence and progression. The prime data source for population-based studies has been SEERMedicare, but SEER data is limited because pathologic information is only abstracted at time of diagnosis. We set out to obtain longitudinal pathology data by developing a natural language processing (NLP) engine to automate abstraction of important details from full text pathology reports.
METHODS: We selected a national random sample of 600 bladder pathology reports from the Department of Veterans Affairs (VA) Corporate Data Warehouse. These reports were independently annotated by two reviewers with discrepancies resolved by a third to develop a gold standard. We used Cohen 0 s kappa to evaluate inter-rater reliability for histology, invasion (presence versus absence and depth), grade, and statements regarding presence of muscularis propria and of carcinoma in situ. Next, we iteratively trained, developed, and tested the NLP engine 0 s ability to abstract these variables from the reports. We assessed NLP performance by calculating accuracy, precision (positive predictive value), and recall (sensitivity).
RESULTS: Inter-rater reliability was excellent between the two reviewers (kappa ranging from 0.82 to 0.90). NLP achieved the highest accuracy for presence of carcinoma in situ (0.98), with accuracy for histology, invasion, grade, and presence of muscularis propria ranging from 0.82 to 0.93 (Table) . The most challenging variable was depth of invasion, due to the high variability in the language used to describe findings. Nevertheless, we achieved acceptable accuracy (0.82) and precision (0.79; table).
CONCLUSIONS: We developed an NLP engine to accurately abstract important pathologic details from full text bladder cancer pathology reports. This engine now allows for abstraction of data from tens of thousands of bladder cancer pathology reports, enabling us to develop a population-based cohort of patients with longitudinal pathology data. The resulting unique dataset will be used to examine the extent to which bladder cancer care impacts recurrence and progression of disease. (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) ) with a diagnosis of high-grade NMIBC who survived 2 years and were not treated with cystectomy or radiation therapy. Patients were assessed for compliance with guideline-based utilization of perioperative Mitomycin C, instillations, cystoscopy, cytology, and Bacillus Calmette-Guerin (BCG) during 2 years of follow-up.
RESULTS: During the 2-year follow-up period, the appropriate utilization of mitomycin C perioperatively showed significant improvement, increasing from 2.5% to 28.2% between 1992-1997 to 2004-2009 (p<0.01) . Individual patients received an average of 6.22 (SD: 6.46) BCG instillations, 4.89 (SD: 1.78) cystoscopies, and 1.77 (SD: 2.13) cytologies. These averages did not increase over the study period. Compliance analysis (Table 1) showed only 40% of patients received at least 1 cystoscopy, 1 cytology, and 1 BCG instillation. Significant predictors of compliance included tumor stage (Tis vs. Ta; OR: 3.0, CI 95% 1.8-5.0; p<0.01) and care at an academic cancer center (vs. non-academic; OR: 9.31, CI 95% 5.6-15.5; p<0.01). Age, gender, marital status, T1 vs. Ta and Charlson comorbidity index were not associated with compliance (all p > 0.05).
CONCLUSIONS: With respect to process measures of highquality NMIBC care, the delivery of perioperative mitomycin improved over time while other care did not improve. The lack of improvement and the variability in care delivery imply that further efforts are needed to improve the dissemination and implementation of guideline-based care. Improving compliance via state-wide quality improvement initiatives, including education and outreach, represents a target for NMIBC quality improvement. METHODS: A Markov model with Monte-Carlo simulation was developed to estimate the incremental cost-effectiveness ratio (ICER) of AUS vs. AdVance sling from a provincial payer perspective over a 10-year period. Probability estimates, success rates, healthcare resources and utilities were obtained from published literature when available or by expert opinion. Cost data included in this model were obtained from provincial health care insurance system and hospital data in 2016-Canadian Dollars.
RESULTS: AUS Implantation had a 10-year mean total cost of $12299 (SDAE3509) for 8.53 quality-adjusted life years (QALYs). On the other hand, AdVance sling had a mean total cost of $20675 (SDAE12435) for 7.98 QALYs. The cost-utility analysis over a 10-year period showed that AUS becomes cost-effective when compared to AdVance sling starting the 4th year in the treatment period. The incremental cost savings of AUS over 10-year period was $8376 with an added effectiveness of 0.55 QALYs. Consequently, the AUS implementation is the dominant strategy over the AdVance sling over a 5-and 10-year time-horizon. CONCLUSIONS: Although the initial cost of sling is attractive, superior long-term outcomes are demonstrated with durable high success rate of AUS in men with severe PPSUI. Hence, the AUS implementation strategy over a 10-year period time is estimated to be more economical to our health care system. More studies are needed to define utility values for health states experienced by males with PPSUI. This will enhance our ability to develop more accurate cost-utility models.
Source of Funding: None

MP32-15 CARE PATHWAY VARIATION AND SURGICAL COST MEASUREMENT FOR PERCUTANEOUS NEPHROLITHOTOMY WITH TIME-DRIVEN ACTIVITY-BASED COSTING
Ian Metzler*, Dylan Issac, Manint Usawachintachit, Matthew Hudnall, Kazumi Taguchi, David Tzou, Tom Chi, San Francisco, CA INTRODUCTION AND OBJECTIVES: The majority of health care cost data are based on charges or reimbursements, but these approaches fail to accurately represent the money hospitals actually spend to provide services. Time-driven activity-based costing (TDABC) provides a methodology to better understand true costs of providing a health care service and the variations in cost based on variance in timing. We applied TDABC analysis to a percutaneous nephrolithotomy (PCNL) care pathway.
METHODS: The care pathway for PCNL was defined as the time from patient arrival to the preoperative area to discharge from post anesthesia care unit (PACU) to the hospital floor. Process maps were created with perioperative stakeholders to define the activities involved in PCNL. Stop-watch timing was performed for eleven PCNL cases. The cost rate for attending urologists was calculated using publicly available salaries and estimated capacity, additional cost rates were estimated using a ratio of the averaged salaries for each staff position.
RESULTS: The activities demonstrating the greatest time variance were PACU recovery, preoperative holding, and stone clearance (214AE100.3, 99AE67.2 and 36AE28.2 minutes respectively). The activities with the least variation were anesthesia extubation, nephrostomy tube placement and patient repositioning (13AE3.9, 9AE4.3, 16AE6.3 minutes respectively). Total cost including disposables and overhead for the average PCNL was $5319. Preoperative care accounted for $470 (7%), intraoperative care accounted for $4351 (84%) and post-operative care accounted for $353 (9%) of the total. Thirty-seven percent of cost was attributable to disposables. Theoretical modeling with an attending performing all perioperative activities (rather than a resident) increased the human resource cost by 31%. Removing the highest time outliers from each activity reduced the cost by 21%.
CONCLUSIONS: Although utilizing the operative room is the most cost intensive activity for PCNL, variation exists during different phases of care. Opportunities for standardization to reduce cost is greatest in the pre-and post-operative areas. The TDABC methodology allows for estimation of true costs for PCNL and modeling of care pathway variation in order to understand health care costs and target areas for increased care value. METHODS: A dedicated ERAS protocol was implemented in our department in July 2015. The subsequent year all consecutive patients were treated according to this protocol (ERAS group). They
